Back to results
US 7,741,349 B2Granted
Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamides
AssigneeAegera Therapeutics, Inc.
InventorsJames B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley Hewitt, H. Nicholas Marsh
Life of this patent
Estimating the term…
Abstract
This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems. Formula I:
Claims6
The compound
- or a pharmaceutically acceptable salt thereof.
The compound
Dependencies are inferred from the claim text.